Damora Therapeutics, Inc.
DMRA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001800315
In the last 90 days, Damora Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 104 institutions reported holding it in 13F filings for Q2 2026, worth $1.67B in total; Viking Global Investors is the only superinvestor holding it.
13F holders, Q2 2021
Institutional positions in Damora Therapeutics, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 27
- +8 vs. Q1 2021
- Shares held
- 11.4M
- −2.32M (−17.0%) vs. Q1 2021
- Total value
- $57.4M
- −$25.6M (−30.8%) vs. Q1 2021
- New holders
- 13
- 3 more added
- Sold out
- 5
- 8 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DMRA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 104 | $1.67B |
| Q1 2026 | 65 | $1.45B |
| Q4 2025 | 18 | $65.5M |
| Q3 2025 | 12 | $633.3K |
| Q2 2025 | 9 | $451.5K |
| Q1 2025 | 11 | $442.4K |
| Q4 2024 | 10 | $660.7K |
| Q3 2024 | 10 | $1.56M |
| Q2 2024 | 22 | $1.91M |
| Q1 2024 | 26 | $3.09M |
| Q4 2023 | 22 | $2.77M |
| Q3 2023 | 22 | $3.92M |
| Q2 2023 | 27 | $25.7M |
| Q1 2023 | 26 | $17.8M |
| Q4 2022 | 22 | $10.2M |
| Q3 2022 | 26 | $17.3M |
| Q2 2022 | 23 | $15.7M |
| Q1 2022 | 25 | $21.0M |
| Q4 2021 | 26 | $30.5M |
| Q3 2021 | 25 | $37.2M |
| Q2 2021 | 27 | $57.4M |
| Q1 2021 | 19 | $82.9M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Damora Therapeutics, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Salem Investment Counselors Inc | 5 | $0 | 0.00% | +5 | New |
| Citigroup Inc | 242 | $1.00K | 0.00% | +242 | New |
| Morgan Stanley | 111 | $1.00K | 0.00% | +111 | New |
| Harbour Investments, Inc. | 300 | $2.00K | 0.00% | +200+200.0% | Added |
| Advisor Group Holdings, Inc. | 400 | $2.00K | 0.00% | +400 | New |
| BlackRock Inc. | 7,304 | $37.0K | 0.00% | −531,592−98.6% | Reduced |
| Tower Research Capital LLC (TRC) | 7,886 | $40.0K | 0.00% | +7,886 | New |
| UBS Group AG | 7,822 | $40.0K | 0.00% | +7,822 | New |
| XTX Topco Ltd | 11,018 | $56.0K | 0.02% | +11,018 | New |
| Federated Hermes, Inc. | 12,000 | $61.0K | 0.00% | −8,000−40.0% | Reduced |
| Virtu Financial LLC | 12,867 | $65.0K | 0.01% | +12,867 | New |
| Vanguard Group Inc | 24,546 | $124.0K | 0.00% | +24,546 | New |
| Blueshift Asset Management, LLC | 25,238 | $128.0K | 0.01% | +25,238 | New |
| Bank of America Corp | 35,490 | $180.0K | 0.00% | +30,542+617.3% | Added |
| Renaissance Technologies LLC | 39,700 | $201.0K | 0.00% | +39,700 | New |
| Wells Fargo & Company | 45,054 | $228.0K | 0.00% | +45,016+118,463.2% | Added |
| Tudor Investment Corp Et Al | 54,100 | $274.0K | 0.01% | −3,857−6.7% | Reduced |
| Asymmetry Capital Management, L.P. | 60,968 | $308.0K | 0.21% | −52,547−46.3% | Reduced |
| Geode Capital Management, LLC | 74,720 | $378.0K | 0.00% | +74,720 | New |
| Laurion Capital Management LP | 207,552 | $1.05M | 0.02% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 208,100 | $1.05M | 0.02% | +208,100 | New |
| Maverick Capital LtdSuperinvestorMaverick Capital | 356,309 | $1.80M | 0.02% | −126,363−26.2% | Reduced |
| Soleus Capital Management, L.P. | 538,152 | $2.72M | 0.42% | −974,496−64.4% | Reduced |
| Janus Henderson Group PLC | 1,299,504 | $6.41M | 0.00% | −22,425−1.7% | Reduced |
| Cormorant Asset Management, LP | 1,753,839 | $8.87M | 0.35% | −396,893−18.5% | Reduced |
| Novo Holdings A/S | 2,497,791 | $12.6M | 0.56% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 4,090,937 | $20.7M | 0.21% | 00.0% | Unchanged |
| Sphera Funds Management Ltd. | 0 | $0 | 0.00% | −448,016−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −133,333−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −82,850−100.0% | Sold out |
| Weiss Multi-Strategy Advisers LLC | 0 | $0 | 0.00% | −16,154−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −13,397−100.0% | Sold out |